DJIA 16,399.67 19.26 0.12%
NASDAQ 4,316.07 57.64 1.35%
S&P 500 1,904.01 17.25 0.91%
market minute promo

Pfizer (NYSE: PFE)

27.93 0.10 (0.36%)

REAL-TIME: Last trade at

Extended Hours: $27.96 $0.03 (0.11%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

PFE $27.93 0.36%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.87
Previous Close $27.83
Daily Range $27.60 - $27.97
52-Week Range $27.51 - $32.96
Market Cap $177.1B
P/E Ratio 17.50
Dividend (Yield) $1.04 (3.7%)
Ex-Dividend Date
Dividend Pay Date
07/30/14
09/03/14
Volume 38,723,628
Average Daily Volume 25,834,615
Current FY EPS $2.26

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary

Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?

The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?

Amgen Sues Sanofi and Regeneron over PCSK9 Candidate - Analyst Blog

Can Valeant's Strong Q3 Entice Allergan?

Week Ahead Market Report: October 20, 2014

Why Pfizer (PFE) Stock Remains a 'Buy' at TheStreet

3 Stocks Reiterated As A Buy: PFE, MU, CELG

Guru Stocks at 52-Week Lows: GOOG, PFE, UN, E, MTU

How to Buy Stocks That Can Make Your Kids Rich

It takes a special kind of stock to produce decades of strong returns. Here's how to find them.

Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?

This recently approved drug has record-breaking potential and could top $10 billion in sales within its first year. Find out the name of this drug and the company behind it.

UPDATE: FDA Has Approved New Labeling on Pfizer's Embeda

See More PFE News...

PFE's Top Competitors

PFE $27.93 (0.36%)
Current stock: PFE
JNJ $99.20 (0.51%)
Current stock: JNJ
ROG $54.76 (0.57%)
Current stock: ROG
GSK $43.61 (-0.14%)
Current stock: GSK